9999999995-24-003902.txt : 20241223 9999999995-24-003902.hdr.sgml : 20241223 20241223001520 ACCESSION NUMBER: 9999999995-24-003902 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20241220 DATE AS OF CHANGE: 20241223 EFFECTIVENESS DATE: 20241220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc. CENTRAL INDEX KEY: 0001806310 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 843199512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-283801 FILM NUMBER: 241569593 BUSINESS ADDRESS: STREET 1: 3000 PEGASUS PARK DRIVE STREET 2: SUITE 1430 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: (214) 612-0000 MAIL ADDRESS: STREET 1: 3000 PEGASUS PARK DRIVE STREET 2: SUITE 1430 CITY: DALLAS STATE: TX ZIP: 75247 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2024-12-20 16:00:00

S-3

0001806310 Taysha Gene Therapies, Inc. 333-283801